Medicare Enrolled

Dr. Asha Kancharla, MD

Pain Medicine · Palestine, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
300 WILLOW CREEK PKWY, Palestine, TX 75801
9037231940
In practice since 2005 (20 years)
NPI: 1225012271 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kancharla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kancharla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kancharla

Dr. Asha Kancharla is a pain medicine in Palestine, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kancharla performed 1,553 Medicare services across 525 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kancharla received a total of $10,200 from 38 pharmaceutical and/or device companies across 519 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kancharla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 44% volume in TX$ $10,200 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,553
Medicare services
Top 44% in TX for pain medicine
525
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~78 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)648$89$225
Steroid injection (triamcinolone)348$1$20
Testing for presence of drug, read by direct observation203$12$420
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level77$82$750
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level75$38$600
New patient office visit (45-59 min)55$113$320
Injection of lower or sacral spine facet joint using imaging guidance, single level49$97$750
Injection of lower or sacral spine facet joint using imaging guidance, second level49$57$1,200
Joint injection, major joint23$49$450
Injection of trigger points, 1-2 muscles14$40$450
Injection of substance into middle or upper spine canal using imaging guidance12$74$750
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,200
Total received (2018-2024)
Avg $1,457/year across 7 years
Top 25% in TX for pain medicine
38
Companies
519
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,200 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,537
2023
$1,811
2022
$1,428
2021
$1,247
2020
$809
2019
$1,876
2018
$1,493

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$1,371
Neurocrine Biosciences, Inc.
$1,206
Alkermes, Inc.
$786
Daiichi Sankyo Inc.
$704
ABBVIE INC.
$668
ITI, Inc.
$606
Otsuka America Pharmaceutical, Inc.
$458
Amgen Inc.
$425
Lundbeck LLC
$417
Avanir Pharmaceuticals, Inc.
$401
Janssen Pharmaceuticals, Inc
$399
Axsome Therapeutics, Inc.
$383
Takeda Pharmaceuticals U.S.A., Inc.
$368
PFIZER INC.
$244
Vanda Pharmaceuticals Inc.
$243
AbbVie Inc.
$205
Ironshore Pharmaceuticals Inc.
$198
Novartis Pharmaceuticals Corporation
$159
Allergan Inc.
$123
JAZZ PHARMACEUTICALS INC.
$119
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$118
Eisai Inc.
$104
Stimwave Technologies Incorporated
$76
IDORSIA PHARMACEUTICALS US INC
$60
Purdue Pharma L.P.
$48
Almatica Pharma LLC
$43
ARBOR PHARMACEUTICALS, INC.
$41
AstraZeneca Pharmaceuticals LP
$30
Arbor Pharmaceuticals, Inc.
$25
Merck Sharp & Dohme Corporation
$25
Assertio Therapeutics, Inc.
$22
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
ASSERTIO THERAPEUTICS, Inc.
$20
Shire North American Group Inc
$19
Indivior Inc.
$19
Avanos Medical
$19
EISAI INC.
$15
Pernix Therapeutics Holdings, Inc.
$15
Top 3 companies account for 33.0% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AIMOVIG · AJOVY · ARISTADA · AUSTEDO · Aimovig · Aristada 441 mg · Austedo XR · Auvelity · BELSOMRA · BRINTELLIX · CAPLYTA · COOLIEF* COOLED RADIOFREQUENCY · Cambia · Dayvigo · EMBEDA · Fanapt · GRALISE · Gralise · HETLIOZ · Horizant · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LOREEV XR · LYBALVI · LYRICA · MOVANTIK · MYDAYIS · Morphabond ER · Movantik · NUEDEXTA · Nuedexta · PERSERIS · QULIPTA · QUVIVIQ · REXULTI · REYVOW · SILENOR · SPRAVATO · SUNOSI · SYMPROIC · Sunosi · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VRAYLAR · XYWAV
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $657 per 100 Medicare services performed
Looking for a pain medicine in Palestine?
Compare pain medicines in the Palestine area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain Medicines within 10 mi
2
Per 100K population
3.5
County median income
$58,846
Nearest hospital
PALESTINE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kancharla is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kancharla experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kancharla performed 648 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kancharla receive payments from pharmaceutical companies?
Yes. Dr. Kancharla received a total of $10,200 from 38 companies across 519 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kancharla's costs compare to other pain medicines in Palestine?
Dr. Kancharla's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kancharla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →